1. The Neuroprotective Effects of Astragaloside IV against H2O2-Induced Damage in SH-SY5Y Cells are Associated with Synaptic Plasticity
    Zurong Song et al, 2020, Journal of Chemistry CrossRef
  2. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury
    Dawei Wang et al, 2017, Journal of Ethnopharmacology CrossRef
  3. Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix)
    Hui‐fei Su et al, 2021, Medicinal Research Reviews CrossRef
  4. Astragaloside IV reverses simvastatin‐induced skeletal muscle injury by activating the AMPK‐PGC‐1α signalling pathway
    Bing Jiang et al, 2020, Phytotherapy Research CrossRef
  5. Integrated therapy decreases the mortality of patients with polymyositis and dermatomyositis: A Taiwan-wide population-based retrospective study
    Ching-Mao Chang et al, 2019, Journal of Ethnopharmacology CrossRef
  6. Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein
    Huang Huang et al, 2016, Canadian Journal of Physiology and Pharmacology CrossRef
  7. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation
    Meng Mei et al, 2015, Environmental Toxicology and Pharmacology CrossRef
  8. Role of Chinese Herbal Medicines in Regulation of Energy Metabolism in Treating Cardiovascular Diseases
    Jie Li et al, 2019, Chinese Journal of Integrative Medicine CrossRef
  9. The inhibitory role of Chinese materia medica in cardiomyocyte apoptosis and underlying molecular mechanism
    YuZhen Li et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  10. Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats
    Xiaoping Wang et al, 2020, Journal of Ethnopharmacology CrossRef
  11. Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?
    Cun Liu et al, 2020, Pharmacological Research CrossRef
  12. Astragaloside IV-targeting miRNA-1 attenuates lipopolysaccharide-induced cardiac dysfunction in rats through inhibition of apoptosis and autophagy
    Qiuning Wang et al, 2021, Life Sciences CrossRef
  13. Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study
    Ching-Mao Chang et al, 2017, Journal of Ethnopharmacology CrossRef
  14. Roles of Chinese herbal medicines in ischemic heart diseases (IHD) by regulating oxidative stress
    Dawei Wang et al, 2016, International Journal of Cardiology CrossRef
  15. Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats
    Cuiyun Huang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  16. Astragaloside IV ameliorates sepsis-induced myocardial dysfunction by regulating NOX4/JNK/BAX pathway
    Yi Su et al, 2022, Life Sciences CrossRef
  17. Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
    Zhen Zhang et al, 2019, Molecular Medicine Reports CrossRef
  18. Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway
    Pei Nie et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  19. Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function
    Yong Luo et al, 2019, Chemico-Biological Interactions CrossRef
  20. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress
    Jiamao Lin et al, 2019, European Journal of Pharmacology CrossRef
  21. Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments
    Can Liu et al, 2022, Pharmacological Research CrossRef